BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

KANEKA PHARMA AMERICA, LLC — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

KANEKA PHARMA AMERICA, LLC

via KING & SPALDING LLP

4th Quarter (Oct 1 - Dec 31) · 2021Posted Jan 10, 2022Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: KANEKA PHARMA AMERICA, LLC
Description: Distributor of life science systems
Location: California · United States of America

Registrant

Firm: KING & SPALDING LLP
Description: Law firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment
LobbyistsWILLIAM CLARKSON · ALLISON F KASSIR · PREEYA NORONHA PINTO · mr DAVID JOSEPH FARBER
Covered position (WILLIAM CLARKSON): Leg. Asst. Sen. Collins; Staff Asst. Sen. Coverdell
Covered position (PREEYA NORONHA PINTO): Deputy GC, Principal Deputy GC, Acting GC, HHS
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.